<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03" generated-datetime="2026-10-08T12:37:28+00:00"><iati-activity last-updated-datetime="2026-02-04T16:05:31+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHR-P83165</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">NIHR RIGHT 1: Prevention of epilepsy from birth-related brain injury</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">The aim of our program is to examine if a pragmatic, evidenced based and generalisable intrapartum care bundle (includes 4 elements birth companion, intelligent auscultation, electronic medical care record, brain oriented neonatal resuscitation) will reduce birth injury related epilepsy at 18 months of age in three public sector hospitals in India. Imperial is the lead institution. University College London is lead for neonatal aEEG and seizure diagnosis. University of Manchester and Liverpool School for Tropical Medicine are lead for birth companion element of care bundle, University of Oxford is lead for Epilepsy and Veevan Ventures is the coordinating site for the participating sites in India.   Objectives:(1) To examine if a pragmatic, evidenced based and generalisable intrapartum care bundle involving birth companions and empowering mothers will reduce birth injury related epilepsy at 18 months of age in India.(2) If effective, incorporate care bundle into the Labour Room Quality Improvement (LaQshya) programme, for national implementation, thus averting approximately 50,000 epilepsy cases every year in India.(3) Provide opportunities for academic and clinical capacity building in India in midwifery, neonatal/paediatric neurology and epilepsy, and public health.</narrative>
  </description>
  <participating-org type="90" role="1">
    <narrative xml:lang="en">National Institute of Health Research (NIHR)</narrative>
  </participating-org>
  <participating-org ref="GB-COH-04465125" type="80" role="4">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <participating-org ref="GB-COH-RC000797" type="80" role="4">
    <narrative xml:lang="en">The University of Manchester</narrative>
  </participating-org>
  <participating-org ref="GB-CHC-222655" type="80" role="4">
    <narrative xml:lang="en">Liverpool School of Tropical Medicine</narrative>
  </participating-org>
  <participating-org ref="GB-UKPRN-10007774" type="80" role="4">
    <narrative xml:lang="en">The University of Oxford</narrative>
  </participating-org>
  <participating-org type="90" role="4">
    <narrative xml:lang="en">Veevan Ventures</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University College London</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Perinatal Brain Research Centre</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Indian Institute of Health Management Research</narrative>
  </participating-org>
  <activity-status code="2"/>
  <activity-date type="2" iso-date="2019-11-01"/>
  <activity-date type="3" iso-date="2025-10-31"/>
  <recipient-country code="IN" percentage="100"/>
  <sector code="13020" percentage="100" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="2">
    <period-start iso-date="2024-08-01"/>
    <period-end iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">2192895.56</value>
  </budget>
  <transaction ref=" Imperial College London Income">
    <transaction-type code="1"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">3340239</value>
  </transaction>
  <transaction ref=" Imperial College London Expenditure">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">2184608.82</value>
  </transaction>
  <transaction ref="Indian Institute of Health Management Research">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">136375</value>
  </transaction>
  <transaction ref="University of Manchester">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">27710</value>
  </transaction>
  <transaction ref="University of Oxford">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">23367.39</value>
  </transaction>
  <transaction ref="Vevaan Ventures">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31"> 1537824</value>
  </transaction>
  <transaction ref="Liverpool School Of Tropical Medicine">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">194901</value>
  </transaction>
  <transaction ref="Perinatal Brain Research Centre">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">52712</value>
  </transaction>
  <transaction ref="University College London">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">105891</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-02-04T16:05:31+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHR-P89503</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">NIHR Global Health Research Group on Physical Trauma from Injury &amp; POsT ConflicT; iPrOTeCT</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">Physical trauma resulting in serious, life changing injuries is endemic in Low- and Middle-Income Countries (LMICs). This project builds on prior work through an understanding of the broader global burden of physical trauma from conflict, non-conflict events such as terror attacks and the growing burden of road traffic accidents due to rapid increases in urbanisation and motor vehicle use. This project works across three continents and will collaborate with some of the largest humanitarian organisations to make change happen. Imperial College London, UK is Co-director of the project and will work on most of the aims. University of Global Health Equity, Rwanda, is the other Co-director and will head the translation activities there with the help of the University of Rwanda. The American University of Beirut, Lebanon, leads on the burden of injury work in the 2006 Lebanon war and gunshot wound project in Gaza. Finally, University of Moratuwa, Sri Lanka, are working on regenerative medicine aspects within the project.</narrative>
  </description>
  <participating-org type="90" role="1">
    <narrative xml:lang="en">National Institute of Health Research (NIHR)</narrative>
  </participating-org>
  <participating-org ref="GB-COH-04465125" type="80" role="4">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Global Health Equity</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Rwanda</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">American University of Beirut</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Moratuwa</narrative>
  </participating-org>
  <participating-org type="21" role="4">
    <narrative xml:lang="en">Legacy of War Foundation</narrative>
  </participating-org>
  <activity-status code="2"/>
  <activity-date type="1" iso-date="2022-09-01"/>
  <activity-date type="3" iso-date="2026-08-31"/>
  <recipient-country code="GB" percentage="60.0"/>
  <recipient-country code="LK" percentage="7.3"/>
  <recipient-country code="LB" percentage="18.3"/>
  <recipient-country code="RW" percentage="14.4"/>
  <sector code="12182" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="2">
    <period-start iso-date="2024-08-01"/>
    <period-end iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">1256816</value>
  </budget>
  <transaction ref="University of Global Health Equity">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">107141</value>
  </transaction>
  <transaction ref=" Imperial College London Income">
    <transaction-type code="1"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">1333545.73</value>
  </transaction>
  <transaction ref="American University of Beirut">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">203446.06</value>
  </transaction>
  <transaction ref="University of Moratuwa">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">99397.73</value>
  </transaction>
  <transaction ref=" Imperial College London Expenditure">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">453995.46</value>
  </transaction>
  <transaction ref="University of Rwanda">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">41963.67</value>
  </transaction>
  <transaction ref="Legacy of War Foundation" humanitarian="0">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">2047</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-02-04T16:05:32+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHR-P89685</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">NIHR Global Health Research Unit and Network for Diabetes and Cardiovascular disease in South Asia</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">Our Global Health Research Network is a partnership between research intensive organisations BRAC in Bangladesh, MDRF and DDF in India, SIMS in Pakistan, UKEL and UCOL in Sri Lanka and the UK, and key collaborators in Australia and Singapore.Our primary ambitions are to: i. improve understanding of the mechanisms underlying the high burdenof Type-2 diabetes (T2D) and cardiovascular disease (CVD) in South Asians, and ii. improve prevention and control of these major diseases through personalised, health systems and policy-based interventions, that are scalable, sustainable, effective and equitable.</narrative>
  </description>
  <participating-org type="90" role="1">
    <narrative xml:lang="en">National Institute of Health Research (NIHR)</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Colombo</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Nanyang Technological University</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Kelaniya</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Devki Devi Foundation</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Services Institute of Medical Sciences</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.52681.38" type="80" role="4">
    <narrative xml:lang="en">BRAC University</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Madras Diabetes Research Foundation</narrative>
  </participating-org>
  <participating-org ref="GB-COH-04465125" type="80" role="4">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <activity-status code="2"/>
  <activity-date type="1" iso-date="2021-09-01"/>
  <activity-date type="3" iso-date="2026-08-31"/>
  <recipient-country code="GB" percentage="49.90"/>
  <recipient-country code="LK" percentage="12.50"/>
  <recipient-country code="SG" percentage="5.50"/>
  <recipient-country code="PK" percentage="4.20"/>
  <recipient-country code="IN" percentage="20.90"/>
  <recipient-country code="BD" percentage="7.00"/>
  <sector code="11120" percentage="15" vocabulary="1"/>
  <sector code="12110" percentage="15" vocabulary="1"/>
  <sector code="12196" percentage="15" vocabulary="1"/>
  <sector code="12261" percentage="15" vocabulary="1"/>
  <sector code="12382" percentage="40" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="2">
    <period-start iso-date="2024-08-01"/>
    <period-end iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">3930992</value>
  </budget>
  <transaction ref="Devki Devi Foundation">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">414471.5</value>
  </transaction>
  <transaction ref="Imperial College London Expenditure">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">2460343.02</value>
  </transaction>
  <transaction ref="Madras Diabetes Research Foundation">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">712660</value>
  </transaction>
  <transaction ref="Imperial College London Income ">
    <transaction-type code="1"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">4797188.57</value>
  </transaction>
  <transaction ref="University of Kelaniya, Sri Lanka">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">390351.43</value>
  </transaction>
  <transaction ref="University of Colombo">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">172089.1</value>
  </transaction>
  <transaction ref="Nanyang Technological University">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">361121.02</value>
  </transaction>
  <transaction ref="Services Institute of Medical Sciences SIMS">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">17399</value>
  </transaction>
  <transaction ref="BRAC James P Grant School of Public Health, BRAC University">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">392250.97</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-02-04T16:05:32+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHR-P90834</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">NIHR Global Health Research Unit on the prevention and management of stillbirths and neonatal deaths in Sub-Saharan Africa  and South Asia</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">Liverpool School of Tropical Medicine is the lead institute for the study. Imperial College is involved in WS6, which involves evaluating how best to support parents, families, attending health providers and communities who experience a stillbirth or neonatal death in India and WS5 which focuses on improving immediate new-born care and resuscitation and parent's involvement in care of sick babies in India.</narrative>
  </description>
  <participating-org type="90" role="1">
    <narrative xml:lang="en">National Institute of Health Research (NIHR)</narrative>
  </participating-org>
  <participating-org ref="GB-CHC-222655" type="80" role="2">
    <narrative xml:lang="en">Liverpool School of Tropical Medicine</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">International Perinatal Epidemiology Unit Private Limited</narrative>
  </participating-org>
  <participating-org ref="GB-COH-04465125" type="80" role="4">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <activity-status code="2"/>
  <activity-date type="1" iso-date="2021-07-01"/>
  <activity-date type="3" iso-date="2026-09-30"/>
  <recipient-country code="IN" percentage="100"/>
  <sector code="13020" percentage="100" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="1">
    <period-start iso-date="2024-08-01"/>
    <period-end iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2024-07-31"> 467671 </value>
  </budget>
  <transaction ref=" Imperial College London Income">
    <transaction-type code="1"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">467671.42</value>
  </transaction>
  <transaction ref="International Perinatal Epidemiology Unit Pvt Ltd">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">44510</value>
  </transaction>
  <transaction ref=" Imperial College London Expenditure">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">44509.8</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-02-04T16:18:15+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-DESNZ-P91322</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">AGROcotton: Agroforestry potential for sustainable cotton growing in Brazil for the fashion                industry</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">Agroforestry systems for Organic Cotton production (OAC) seek to play a pivotal role in                addressing climate change and supporting a green and inclusive recovery in Brazil. AGROcotton seeks to                build capacity for OAC production and develop scalable business models for sustainable OAC supply chains                in Brazil, contributing to; (i) sustained reduction of GHG emissions, (ii) greenand resilient recovery                reducing deforestation, biodiversity loss and water stress, and (iii) inclusive recovery generating                income opportunities for marginalised communities. AGROcotton sorted deliver:1. Spatial analysis of land                suitability and potentials of OAC in Brazil (ICL). To promote the outcome, Task 1 will facilitate the                scale-up and replicability of OAC projects employ GIS-based Multi-Criteria Analysis to quantify suitable                areas (high, medium and low suitability) and geolocate most suitable areas in the Midwest, Northeast and                North regions of Brazil.2. Capacity building in Mato Grosso (FF &amp; ICL). To advance the outcome, Task                2 will improve the capacity of small-scale farmers to implement OAC systems by training between 20 and                100 small-scale, vulnerable farmers on financial, management and agricultural aspects of OAC systems.3.                Implementation of OAC pilot cases in Mato Grosso (FF &amp; ICL). To promote the outcome, Task 3 will                generate experience with the execution of OAC systems by cultivating 20 ha of degraded forest                integrating cotton with other crops.4. Environmental analyses (ICL &amp; FF). To advance the outcome,                Task 4 will provide critical knowledge of the environmental impacts of OAC systems by quantifying                emissions of Greenhouse Gases, consumption and pollution of water and impacts on biodiversity with Life                Cycle approach, based on experimental data from Mato Grosso. Also, changes of land use and land cover,                both direct and indirect, will be monitored and quantified. 5. Socio-economic and financial analyses                (ICL &amp; FF). To promote the outcome, Task 5 will analyse the financial and socio-economic impacts of                OAC systems at farm level, based on experimental data from Mato Grosso. 6. AGROcotton guidelines for OAC                (FF &amp; ICL). To advance the outcome, Task 6 will facilitate the replicability of OAC projects and                inspire future action by developing a set of OAC guidelines synthetizing empirical evidence and lessons                learnt from T2, 3, 4 and 5 of AGROcotton. 7. Market analysis (UB &amp; FF). To promote the outcome, Task                7 will characterise the potential market of OAC in Brazil by mapping supply chain actors and drivers,                considering prices, willingness to pay and the importance of traceability and certification. 8. Policy                analysis and recommendations (UB). To promote the outcome, Task 5 will recommend policies and programmes                for OAC systems in Brazil (UB). To promote the outcome, Task 5 will recommend policies and programmes                for OAC systems in Brazil based on an analysis of existing policies in agriculture and forestry and                expert interviews. 9. Dissemination and communication activities (FF, ICL &amp; UB). To advance the                outcome, Task 6 will communicate and disseminate widely the outputs of AGROcotton and by initiating the                establishment of a national stakeholder platform for OAC.</narrative>
  </description>
  <participating-org ref="GB-COH-04465125" type="80" role="4">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">FarFarm</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Brasília</narrative>
  </participating-org>
  <participating-org type="10" role="1">
    <narrative xml:lang="en">Department for Energy Security and Net Zero (DESNZ)</narrative>
  </participating-org>
  <other-identifier ref="GB-COH-04465125-BEIS_P91322" type="A3">
    <owner-org ref="GB-COH-04465125">
      <narrative xml:lang="en">Identifier changed to GB-COH-04465125-DESNZ_P91332 to reflect funding organisation</narrative>
    </owner-org>
  </other-identifier>
  <activity-status code="4"/>
  <activity-date type="2" iso-date="2021-08-01"/>
  <activity-date type="4" iso-date="2022-08-31"/>
  <recipient-country code="BR" percentage="100"/>
  <sector code="31210" percentage="100" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="2">
    <period-start iso-date="2021-07-01"/>
    <period-end iso-date="2021-07-31"/>
    <value currency="GBP" value-date="2022-07-31">305306.40</value>
  </budget>
  <transaction>
    <transaction-type code="1"/>
    <transaction-date iso-date="2022-07-31"/>
    <value currency="GBP" value-date="2022-07-31">140729.26</value>
  </transaction>
  <transaction>
    <transaction-type code="4"/>
    <transaction-date iso-date="2022-07-31"/>
    <value currency="GBP" value-date="2022-07-31">174409.51</value>
    <provider-org ref="FR17" type="80">
      <narrative xml:lang="en">Imperial College London</narrative>
    </provider-org>
    <receiver-org ref="FR17" type="80">
      <narrative xml:lang="en">Farfarm Consultoria Ltda</narrative>
    </receiver-org>
  </transaction>
  <transaction>
    <transaction-type code="1"/>
    <transaction-date iso-date="2023-07-31"/>
    <value currency="GBP" value-date="2023-07-31">129247.70</value>
  </transaction>
  <transaction ref="Farfarm Consultoria Ltd">
    <transaction-type code="4"/>
    <transaction-date iso-date="2023-07-31"/>
    <value currency="GBP" value-date="2023-07-31">176058.98</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-02-04T16:18:15+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHR-P88207</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">What is the cost of poor quality medicine? Estimating the prevalence, health impact and economic                cost of substandard and falsified medicines in Indonesia in the age of Universal Health Coverage</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">Efforts by low and middle income countries (LMICs) to achieve universal health coverage (UHC) are                often constrained by inadequate resources. As demands on health systems expand, pressure to contain                costs can threaten quality, including the quality of medicines on which all health systems rely. While                the WHO believes substandard and falsified medicines (S&amp;F meds) are on the rise, there are no agreed                methods for measuring the problem, and thus no way of tracking progress in ensuring that medicines newly                available to poorer patients through UHC efforts are safe and effective. Indonesia has vastly expanded                its national health insurance since 2014; it now undertakes to provide free medicine to 222 million                people, over 80% of citizens in the world's fourth most populous nation. Procurement policies that                prioritise low cost over quality aim to reduce the deficit of £1.9 bln but have raised concerns,                magnified by several recent scandals, that UHC is expanding access to S&amp;F meds. Objectives: We aim                to support national efforts to ensure that Indonesians, especially the poorest who rely on insurance or                informal markets, have consistent access to quality medicine. We will do this by working with the                medicine regulator and intersectoral partners to better understand and quantify the prevalence and                distribution of S&amp;F meds nationally. In the process, we will:1. Trial new methods for risk-based                sentinel surveillance for S&amp;F meds;2. Develop robust, adaptable tools to estimate the prevalence,                health impact and cost of S&amp;F meds;3. Pioneer the use of the tools, making the first national                estimates of S&amp;F meds in any LMIC;4. Engage continuously with policy partners to facilitate                appropriate intersectoral responses in Indonesia, and to adapt tools for other LMICs.5) Promote                institutionalisation of academic-policy partnerships to support the ongoing production and use of                medicine policy research in Indonesia.</narrative>
  </description>
  <participating-org type="90" role="1">
    <narrative xml:lang="en">National Institute of Health Research (NIHR)</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Universitas Pancasila</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Erasmus University</narrative>
  </participating-org>
  <participating-org ref="GB-COH-04465125" type="80" role="4">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <activity-status code="4"/>
  <activity-date type="1" iso-date="2020-11-01"/>
  <activity-date type="2" iso-date="2020-11-01"/>
  <activity-date type="3" iso-date="2023-12-31"/>
  <recipient-country code="ID" percentage="60"/>
  <recipient-country code="GB" percentage="30"/>
  <recipient-country code="NL" percentage="10"/>
  <sector code="12196" vocabulary="1">
    <narrative xml:lang="en">Health statistics and data Collection, production, management and dissemination of statistics and                data related to health. Includes health surveys, establishment of health databases, data collection on                epidemics, etc.</narrative>
  </sector>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="1">
    <period-start iso-date="2023-08-01"/>
    <period-end iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">2041486.64</value>
  </budget>
  <transaction ref="Imperial College London Income">
    <transaction-type code="1"/>
    <transaction-date iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">2043030.64</value>
  </transaction>
  <transaction ref="Imperial College London Expenditure">
    <transaction-type code="4"/>
    <transaction-date iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">2040944.18</value>
  </transaction>
  <transaction ref="Universitas Pancasila">
    <transaction-type code="4"/>
    <transaction-date iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">145919.64</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-02-04T16:18:16+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHR-P94067</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">NIHR Health Financing Fragmentation and Universal Health Coverage in Brazil, Colombia, Mexico and India</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">The way health systems are structured and financed has major implications for the quality and comprehensiveness of the services they deliver, whether patients use those services, how much they cost and who pays, and whether they deliver improvements in health outcomes.  In many low- and middle-income countries (LMICs) health financing is highly fragmented and can negatively impact health system goals including ensuring access to high quality care to all patients, irrespective of their ability to pay. This research programme generates evidence from four countries: Brazil, Colombia, Mexico and India. The research aims to quantify the nature and variation of financing fragmentation in the four countries, investigate how financing fragmentation affects health system goals, and understand the political factors which drive financing fragmentation.  https://hs-fragmentation.org/</narrative>
  </description>
  <participating-org ref="GB-COH-04465125" type="80" role="4">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <participating-org ref="GB-COH-RC000679" type="80" role="4">
    <narrative xml:lang="en">University of York</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">O.P. Jindal Global University</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Universidad Nacional de Colombia</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">National Institute of Public Health of Mexico (INSP)</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Instituto De Estudos Para Políticas Da Saúde (IEPS)</narrative>
  </participating-org>
  <participating-org type="90" role="1">
    <narrative xml:lang="en">National Institute of Health Research (NIHR)</narrative>
  </participating-org>
  <activity-status code="2"/>
  <activity-date type="1" iso-date="2022-10-01"/>
  <activity-date type="3" iso-date="2026-09-30"/>
  <recipient-country code="MX" percentage="25"/>
  <recipient-country code="IN" percentage="25"/>
  <recipient-country code="CO" percentage="25"/>
  <recipient-country code="BR" percentage="25"/>
  <sector code="12196" percentage="20" vocabulary="1"/>
  <sector code="12110" percentage="60" vocabulary="1"/>
  <sector code="12182" percentage="20" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="1">
    <period-start iso-date="2024-08-01"/>
    <period-end iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">3109465</value>
  </budget>
  <transaction ref="University of York">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">284721</value>
  </transaction>
  <transaction ref="INSTITUTO DE ESTUDOS PARA POLÍTICAS DA SAÚDE (IEPS)">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">467880</value>
    <provider-org type="80"/>
    <receiver-org type="80"/>
  </transaction>
  <transaction ref=" Imperial College London Income">
    <transaction-type code="1"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">2166289.31</value>
  </transaction>
  <transaction ref="Universidad Nacional de Colombia">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">570861</value>
  </transaction>
  <transaction ref="O P Jindal Global University">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">375556</value>
  </transaction>
  <transaction ref="Instituto Nacional de Salud Publica">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">451274</value>
  </transaction>
  <transaction ref=" Imperial College London Expenditure">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">2150292.31</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-02-04T16:18:16+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHR-PA1845</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">NIHR Global Health Research Centre for Non-communicable Diseases and Environmental Change</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">The NIHR Global Health Research Centre for non-communicable diseases (NCDs) and Environmental Change will be a recognised centre of excellence on NCDs and global environmental change in low and middle-income countries (LMICs), offering world-leading research, training and policy advice for health equity within 5 years. It includes four LMIC-based institutions working in three countries, Bangladesh, India, and Indonesia. The target NCDs are hypertension, diabetes, cardiovascular diseases (CVD), chronic kidney disease (CKD) and Chronic obstructive pulmonary disease (COPD).The Centre addresses crucial knowledge gaps through three integrated research themes: •Strengthening primary health care and essential public health services for NCD prevention and management in communities affected by rapid environmental change; •Developing and evaluating multi-sectoral interventions that have dual benefits in reducing the burden of NCDs and hazardous environmental exposures at the population level; •Strengthening engagement of communities in the generation and use of evidence and advocacy for health and environment policy change.The Centre focusses on strengthening primary health care through establishment of a digital platform, and developing and evaluating multi-sectoral interventions addressing coastal water salinity and hypertension in Bangladesh, leveraging food aid for NCD prevention in India and reducing effects of plastics burning and air pollution in Indonesia. Community engagement and involvement activities will be key in the evidence-to-policy process in each of the research focus areas to identify opportunities for strengthening impact outcomes.Throughout the research lifecycle, the Centre emphasises systematic and meaningful engagement of community members and policymakers – including through co-design and evaluation of interventions. In addition to delivering high-quality impactful research, research capacity strengthening is a top priority. The Centre is delivering several training and development opportunities targeting three critical career periods: (1) pre-doctoral, (2) early post-doctoral and (3) transitioning to senior leadership.The Centre’s Theory of Change aims to bring positive impact through:-•Enhanced health equity, wellbeing and environmental sustainability across Asia (SDGs 3, 5, 10, 13, and 17); •Strengthened research infrastructure for generating high-quality evidence on NCDs in populations most vulnerable to environmental change; •Mobilised CEI capability to ensure evidence, advocacy and policy action is community-centric and benefits the most vulnerable.</narrative>
  </description>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Brawijaya University</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Sri Ramachandra Institute of Higher Education and Research</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Portsmouth</narrative>
  </participating-org>
  <participating-org ref="GB-COH-04465125" type="80" role="4">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <participating-org ref="IN-MCA-U74900TG2007NPL055085" type="80" role="4">
    <narrative xml:lang="en">George Institute for Global Health</narrative>
  </participating-org>
  <participating-org ref="XM-OCHA-4438" type="80" role="4">
    <narrative xml:lang="en">International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)</narrative>
  </participating-org>
  <participating-org ref="GB-GOV-10" type="10" role="1">
    <narrative xml:lang="en">UK - Department of Health and Social Care (DHSC)</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">The Manchester Metropolitan University</narrative>
  </participating-org>
  <activity-status code="2"/>
  <activity-date type="1" iso-date="2022-10-01"/>
  <activity-date type="3" iso-date="2027-09-30"/>
  <recipient-country code="IN" percentage="33.33"/>
  <recipient-country code="ID" percentage="33.33"/>
  <recipient-country code="BD" percentage="33.34"/>
  <sector code="12382" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="1">
    <period-start iso-date="2024-08-01"/>
    <period-end iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">7311216</value>
  </budget>
  <transaction ref=" Imperial College London Expenditure">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">3748752.16</value>
  </transaction>
  <transaction ref=" Imperial College London Income">
    <transaction-type code="1"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">3807443</value>
  </transaction>
  <transaction ref="Brawijaya University">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">972125.91</value>
  </transaction>
  <transaction ref="International Centre for Diarrhoeal Disease Research">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">930955.82</value>
  </transaction>
  <transaction ref="George Institute for Global Health">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">1372338</value>
  </transaction>
  <transaction ref="Sri Ramachandra Institute of Higher Education and Research">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">457260</value>
  </transaction>
  <transaction ref="University of Portsmouth">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">14241.3</value>
  </transaction>
  <transaction ref="The Manchester Metropolitan University">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">1831.13</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-02-04T16:20:00+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-BMPF-P67348</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">NIHR Group on POsT Conflict Trauma (PrOTeCT) Trauma in Sri Lanka</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">The NIHR Global Health Research Group on Post Conflict Trauma; PrOTeCT, was a                collaborative grant between Imperial College London (UK), the University of Moratuwa (Sri Lanka) and the                American University of Beirut (Lebanon). It brought together expertise in trauma practice, engineering                and clinical research.&#13;The clinical goal for this NIHR Group was limb salvage for victims of                conflict trauma. Within the lifetime of the grant, and beyond, we aimed to deliver measurable benefits                to people in LMIC countries who have suffered injuries as a result of conflicts. We wanted to identify                the types of injuries that have led to early amputation and those which are amendable to salvage. In                addition, we aimed to develop and to clinically deploy technology for limb salvage and limb regeneration                that will be appropriate wherever blast injuries occur.</narrative>
  </description>
  <description type="2">
    <narrative xml:lang="en">To achieve this, we had the following research aims:&#13;1) Identify patient                characteristics that have led to early avoidable amputation;&#13;2) Provide immediate surgeon education                for limb salvage/amputation using state of the art techniques;&#13;3) Develop simple, low cost bespoke                instruments and implantable devices to maximise the extent of limb salvage.</narrative>
  </description>
  <description type="4">
    <narrative xml:lang="en">The PrOTeCT Group successful designed an external fixator for use after traumatic injury,                progressed regenerative medicine scaffolds towards future use in limb salvage and gained insights into                the clinical burden of war injuries.</narrative>
  </description>
  <participating-org ref="GB-HESA-GB-COH-04465125" type="80" role="4" crs-channel-code="10000">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <participating-org type="80" role="4" crs-channel-code="63000">
    <narrative xml:lang="en">American University of Beirut</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Moratuwa</narrative>
  </participating-org>
  <participating-org type="90" role="1">
    <narrative xml:lang="en">National Institute of Health Research (NIHR)</narrative>
  </participating-org>
  <activity-status code="3"/>
  <activity-date type="2" iso-date="2017-08-01"/>
  <activity-date type="3" iso-date="2022-10-18"/>
  <recipient-country code="LB" percentage="14"/>
  <recipient-country code="LK" percentage="10"/>
  <recipient-country code="GB" percentage="76"/>
  <sector code="32182" percentage="100" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="1">
    <period-start iso-date="2023-08-01"/>
    <period-end iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">2365936.46</value>
  </budget>
  <transaction ref=" Imperial College London Expenditure">
    <transaction-type code="4"/>
    <transaction-date iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">2179335.05</value>
  </transaction>
  <transaction ref=" Imperial College London Income">
    <transaction-type code="1"/>
    <transaction-date iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">2247640.79</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-02-04T16:20:00+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHR-P68219</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">NIHR Global Health Research Unit for Cardiovascular Disease and Diabetes</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">The Programme is now complete. Our Global Health Research Unit has focussed on research for the                benefit of people living in&#13;Bangladesh, India, Pakistan and Sri Lanka. In collaboration with our                research partners in South Asia: BRAC in Bangladesh, MDRF and DDF in India, SIMS in Pakistan, UKEL and                UCOL in Sri Lanka and the UK, and key collaborators in Australia and Singapore.</narrative>
  </description>
  <participating-org type="90" role="1">
    <narrative xml:lang="en">National Institute of Health Research (NIHR)</narrative>
  </participating-org>
  <participating-org ref="GB-COH-04465125" type="80" role="4">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Nanyang Technological University</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Kelaniya</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Devki Devi Foundation</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Colombo</narrative>
  </participating-org>
  <activity-status code="3"/>
  <activity-date type="2" iso-date="2017-06-01"/>
  <activity-date type="4" iso-date="2021-09-30"/>
  <recipient-country code="GB" percentage="57.5"/>
  <recipient-country code="LK" percentage="6.0"/>
  <recipient-country code="IN" percentage="20.0"/>
  <recipient-country code="PK" percentage="5.5"/>
  <recipient-country code="BD" percentage="11.0"/>
  <sector code="11120" percentage="20" vocabulary="1"/>
  <sector code="12110" percentage="10" vocabulary="1"/>
  <sector code="12196" percentage="15" vocabulary="1"/>
  <sector code="12261" percentage="15" vocabulary="1"/>
  <sector code="12382" percentage="40" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="2">
    <period-start iso-date="2023-08-01"/>
    <period-end iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">6997610</value>
  </budget>
  <transaction ref=" Imperial College London Expenditure">
    <transaction-type code="4"/>
    <transaction-date iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">6804737.32</value>
  </transaction>
  <transaction ref=" Imperial College London Income">
    <transaction-type code="1"/>
    <transaction-date iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">6768449.43</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-02-04T16:20:01+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHR-P82837</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">Addressing Health System Fragmentation to Advance Universal Health Coverage for Low                Income Populations in Latin America</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">Development grant to build collaborations, stakeholder engagement, and priority                setting for larger research grant on health systems research. Partners include Instituto De Estudos Para                Políticas Da Saúde (IEPS) in Brazil and National Institute of Public Health in Mexico.</narrative>
  </description>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Instituto De Estudos Para Políticas Da Saúde (IEPS)</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">National Institute of Public Health</narrative>
  </participating-org>
  <participating-org type="90" role="1">
    <narrative xml:lang="en">National Institute of Health Research (NIHR)</narrative>
  </participating-org>
  <participating-org ref="GB-COH-04465125" type="80" role="4">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <activity-status code="4"/>
  <activity-date type="2" iso-date="2020-03-01"/>
  <activity-date type="3" iso-date="2020-11-30"/>
  <activity-date type="4" iso-date="2023-09-30"/>
  <recipient-country code="MX" percentage="6"/>
  <recipient-country code="BR" percentage="94"/>
  <sector code="12110" percentage="100" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="2">
    <period-start iso-date="2023-08-01"/>
    <period-end iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">92245.22</value>
  </budget>
  <transaction ref=" Imperial College London Expenditure">
    <transaction-type code="4"/>
    <transaction-date iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">98087.91</value>
  </transaction>
  <transaction ref=" Imperial College London Income">
    <transaction-type code="1"/>
    <transaction-date iso-date="2024-07-31"/>
    <value currency="GBP" value-date="2024-07-31">96845.22</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-06-04T11:08:50+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHR-PA3631</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">Innovating with Mhealth in Peru for dementiA and Co-morbidiTies</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">Health systems in LMICs are poorly equipped to care for chronic mental and physical disease, which are rapidly increasing with aging populations. Cognitive impairment challenges health systems on multiple fronts, incurring huge human and financial costs. Latin America has the highest projected increase in dementia incidence globally, and in Peru there are ~300,000 people with dementia (PWD). Many are undiagnosed and lack basic support. Care is often provided exclusively by family members. IMPACT Dement is a new 4-year project funded by the Global Health programme of the NIHR, which will tackle inequity in access to dementia care and diagnosis in Peru and beyond using sustainable, integrated, person-centred, community-delivered, technology-enabled innovation. https://impact-salud.org</narrative>
  </description>
  <participating-org ref="GB-COH-04465125" role="2">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <participating-org ref="University of Cardiff" role="4">
    <narrative xml:lang="en">University of Cardiff</narrative>
  </participating-org>
  <participating-org ref="PE-SUNARP-03024345" role="4">
    <narrative xml:lang="en">Universidad Peruana Cayetano Heredia</narrative>
  </participating-org>
  <participating-org ref="GB-UKPRN-10007790" role="4">
    <narrative xml:lang="en">University of Edinburgh</narrative>
  </participating-org>
  <participating-org ref="GB-UKPRN-10007774" role="4">
    <narrative xml:lang="en">The University of Oxford</narrative>
  </participating-org>
  <participating-org ref="AU-ABN-15211513464" role="4">
    <narrative xml:lang="en">University of Sydney</narrative>
  </participating-org>
  <activity-status code="2"/>
  <activity-date type="1" iso-date="2022-11-01"/>
  <activity-date type="3" iso-date="2026-10-31"/>
  <activity-scope code="1"/>
  <recipient-country code="PE" percentage="75"/>
  <recipient-country code="GB" percentage="25"/>
  <sector code="12110" percentage="15" vocabulary="1"/>
  <sector code="12261" percentage="20" vocabulary="1"/>
  <sector code="12340" percentage="25" vocabulary="1"/>
  <sector code="12382" percentage="40" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="1">
    <period-start iso-date="2024-08-01"/>
    <period-end iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">3139619</value>
  </budget>
  <transaction ref="Universidad Peruana Cayetano Heredia" humanitarian="0">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">987239</value>
  </transaction>
  <transaction ref="Total Income to date">
    <transaction-type code="1"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">1647768</value>
  </transaction>
  <transaction ref="The University of Sydney">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">46477</value>
  </transaction>
  <transaction ref="University of Oxford" humanitarian="0">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">102175</value>
  </transaction>
  <transaction ref="University of Edinburgh" humanitarian="0">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">23283</value>
  </transaction>
  <transaction ref="Imperial College London Expenditure" humanitarian="0">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">1212771</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-09-16T16:28:33+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHRPB0552</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">NIHR A Simplified screen-and-Treat-all prOphylaxis approach in Pregnant women to stop Hepatitis B Virus mother-to-child transmission in Malawi and The Gambia (STOP-HBV)</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">"Project Summary&#13;
&#13;
The NIHR STOP-HBV project is a multi-country global health research programme funded by the National Institute for Health and Care Research (NIHR) and led by Imperial College London. The project aims to strengthen hepatitis B virus (HBV) prevention, diagnosis, and care pathways in sub-Saharan Africa, contributing to progress towards WHO hepatitis elimination targets.&#13;
&#13;
HBV remains a major cause of liver cirrhosis and liver cancer in Africa, with limited access to systematic screening, laboratory monitoring, and long-term antiviral treatment. STOP-HBV addresses these gaps through implementation research embedded within routine health systems. The project combines clinical research, laboratory strengthening, capacity building, and policy translation to develop scalable and sustainable models of care.&#13;
&#13;
The programme focuses on improving:&#13;
	•	Identification of pregnant women and adults living with chronic HBV&#13;
	•	Linkage to specialist liver care&#13;
	•	Access to antiviral treatment&#13;
	•	Monitoring of liver disease progression&#13;
	•	Integration of HBV services within national health systems&#13;
&#13;
The project also strengthens local research capacity through training of PhD students, project managers, and clinical researchers, and supports institutional governance and data management systems.&#13;
&#13;
Countries Involved and Specific Roles: &#13;
&#13;
United Kingdom&#13;
Imperial College London (Lead Contractor and Sponsor)&#13;
Imperial College London leads and coordinates the overall project. Responsibilities include:&#13;
	•	Scientific leadership (Chief Investigator: Prof. Maud Lemoine)&#13;
	•	Overall project governance and management&#13;
	•	Sponsor responsibilities and regulatory oversight&#13;
	•	Central financial management&#13;
	•	Contracts and partner agreements&#13;
The Gambia&#13;
MRC Unit The Gambia at the London School of Hygiene &amp; Tropical Medicine (LSHTM)&#13;
The Gambia site hosts the West African implementation component of STOP-HBV. Responsibilities include:&#13;
	•	Participant recruitment and follow-up within antenatal and clinical services&#13;
	•	Delivery of HBV screening and clinical management&#13;
	•	Laboratory testing (virology and liver disease assessment)&#13;
	•	Local data collection and management&#13;
	•	Engagement with the Ministry of Health for translation into policy&#13;
	•	Contribution to scientific outputs and dissemination&#13;
University of Liverpool (UK)&#13;
The University of Liverpool collaborates through its long-standing partnership with MLW. Responsibilities include:&#13;
	•	Academic oversight and co-investigator input&#13;
	•	Clinical research leadership in Malawi (Dr Alexander Stockdale and collaborators)&#13;
	•	Data analysis and interpretation&#13;
	•	Contribution to publications and capacity building&#13;
&#13;
United Kingdom&#13;
Canterbury Christ Church University (CCCU)&#13;
	•	Implementation science and public health expertise&#13;
	•	Support for evaluation methodology and health systems analysis&#13;
	•	Contribution to capacity building and training activities&#13;
	•	Participation in dissemination and knowledge translation&#13;
CCCU contributes academic expertise but does not hold ownership of in-country Research Data.&#13;
&#13;
Malawi&#13;
Kamuzu University of Health Sciences (KUHeS)&#13;
	•	National academic partner in Malawi&#13;
	•	Integration of research within medical education and health workforce development&#13;
	•	Clinical collaboration through QECH&#13;
	•	Strengthening institutional research capacity&#13;
	•	Contribution to sustainability and translation into national policy&#13;
&#13;
Coolaborators do also include: &#13;
Malawi Liverpool Wellcome Programme (MLW)&#13;
Governmental health facilities The Gambia &#13;
Young Gambian Fund, The Gambia &#13;
World Hepatitis Alliance &#13;
&#13;
	•	Host institution for Malawi implementation site&#13;
	•	Embedded within Queen Elizabeth Central Hospital (QECH), Blantyre&#13;
	•	Recruitment and follow-up of pregnant women&#13;
	•	Laboratory diagnostics and viral load monitoring&#13;
	•	Implementation research and community engagement&#13;
	•	Local regulatory compliance and governance&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
"</narrative>
  </description>
  <participating-org role="4">
    <narrative xml:lang="en">MRC Unit The Gambia at the London School of Hygiene &amp; Tropical Medicine (MRCG)</narrative>
  </participating-org>
  <participating-org role="4">
    <narrative xml:lang="en">Kamuzu University of Health Sciences (KUHeS)</narrative>
  </participating-org>
  <participating-org role="4">
    <narrative xml:lang="en">University of Liverpool</narrative>
  </participating-org>
  <participating-org role="4">
    <narrative xml:lang="en">Canterbury Christ Church University</narrative>
  </participating-org>
  <activity-status code="2"/>
  <activity-date type="1" iso-date="2026-03-01"/>
  <recipient-country code="MW" percentage="30">
    <narrative xml:lang="en">71% of the funds are allocated to LMICs partner.</narrative>
  </recipient-country>
  <recipient-country code="GM" percentage="41">
    <narrative xml:lang="en">71% of the funds are allocated to LMICs partner.</narrative>
  </recipient-country>
  <recipient-country code="GB" percentage="29"/>
  <sector code="12110" percentage="50" vocabulary="12"/>
  <sector code="12196" percentage="50" vocabulary="12"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="2">
    <period-start iso-date="2026-03-01"/>
    <period-end iso-date="2027-02-28"/>
    <value currency="GBP" value-date="2026-03-01">2966810.77</value>
  </budget>
  <transaction ref="Kamuzu University of Health Sciences (KUHeS)" humanitarian="0">
    <transaction-type code="2"/>
    <transaction-date iso-date="2026-07-31"/>
    <value currency="GBP" value-date="2026-07-31">880050</value>
    <receiver-org type="15"/>
  </transaction>
  <transaction ref="Canterbury Christ Church University (CCCU)">
    <transaction-type code="2"/>
    <transaction-date iso-date="2026-07-31"/>
    <value currency="GBP" value-date="2026-07-31">64250</value>
  </transaction>
  <transaction ref="University of Liverpool (UK)">
    <transaction-type code="2"/>
    <transaction-date iso-date="2026-07-31"/>
    <value currency="GBP" value-date="2026-07-31">402152</value>
  </transaction>
  <transaction ref="MRC Unit The Gambia @ LSHTM">
    <transaction-type code="2"/>
    <transaction-date iso-date="2026-07-31"/>
    <value currency="GBP" value-date="2026-07-31">1223336</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-09-24T16:13:43+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHR-P93366</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">NIHR Global Health Research Group on Digital Diagnostics for African  Health Systems</narrative>
  </title>
  <description type="1">
    <narrative xml:lang="en">The Project aims to investigate whether a new type of diagnostic test, called a digital diagnostic, will be better than currently available diagnostic tests in African health care settings. We aim to evaluate whether digital diagnostics technology will work properly, whether it will provide accurate diagnoses, and whether we can optimise it to give the maximum chance that it is adopted intopractice in African healthcare systems. To do this, we need to fully understand the context in which it will be used, and understand the perspectives of all of those who might be impacted, from the patients and healthcare workers right up to ministries of health and international policy makers. We do this through different types of interviews and focus groups. We optimise the design of digital diagnostics in partnership with the intended users – so called “co-design”. We assess the potential impact on health systems to understand how other aspects of diagnosis and care might be affected. We compare accuracy of diagnoses using our digital diagnostics technology against those of the best possible "gold standard" diagnostic tests, and also against any tests in common use in Africa.We want to look at different scenarios where there are important gaps in the availability, accuracy, or data collection from currentdiagnostic tests. These scenarios are:   1. detection of malaria parasites;   2. cause of fever in young children;   3. detecting bacterial contamination of water and food. The countries where the research is underatken are:   - The Gambia  - Ghana   - Burkina Faso  - Kenya   - Sudan   - Zambia The research plan is structured in 6 cross-cutting Work Packages and 10 Sub-Projects as follows: WP1 | Technology Development Lead: Prof. Pantelis Georgiou (Imperial College London)WP2 | Community Engagement and InvolvementLead: Prof. Salome Bukachi (University of Nairobi)WP3 | Diagnostic Evaluation Leads: Dr Jane Achan (Malaria Consortium), Dr Samuel Duodu (University of Ghana)WP4 | Health Systems Lead: Dr Julie Balen (University of Sheffield)WP5 | User Interface Co-designLead: Dr Talya Porat (Imperial College London)WP6 | Data Integration and ApplicationLeads: Prof. Céire Costelloe (Institute of Cancer Research), Mr Darlington Akogo (minoHealth AISP1 |  Evaluation of the detection of asymptomatic carriage of malaria parasites in cross-sectional community screening surveys using a point of care digital diagnostic PhD Student: Dimbintsoa Robinson, MRC Unit The Gambia (LSYTM) – Supervisors: Prof. D'Alessandro, Prof Tinto                 SP2 |  Evaluation of the detection of malaria parasite species and anti-malarial resistance in uncomplicated malaria patients using a point of care digital diagnostic  PhD Student: Martin Chamai, University of Ghana, WACCBIP – Supervisors: Dr Amoah, Prof. AwandareSP3 |  Evaluation of the detection of malaria in pregnancy and anti-malarial drug resistance using a point of care digital diagnostic PhD Student: Jean-Bertin Kabuya, Tropical Diseases Research Centre – Supervisor: Prof. Christine ManyandoSP4 |  Evaluation of detection of P. falciparum and P. Vivax malaria and G6PD deficiency using a point of care digital diagnostic PhD Student: Waleed Mohammed Alhaj Jebreel, University of Khartoum, IEND – Supervisors: Prof. Osman, Prof. MahdiSP5 |  Evaluating a digital diagnostic to distinguish between causes of childhood febrile illness PhD Student: Flavian Akite, University of Ghana, WACCBIP – Supervisors: Dr Duodu, Dr Usuf, Dr CunningtonSP6 |  Developing and evaluating a digital diagnostic for environmental pathogen detection PhD Student: Erick Odoyo, Masinde Muliro University of Science and Technology (MMUST) – Supervisors: Dr Sifuna, Dr Rodriguez ManzanoSP7 |  Evaluating digital diagnostic implementation through national and international health policy &amp;   health systems analysis PhD Student: Shola Kelly Molemodile Dele-Olowu, University of Ghana – Supervisors: Dr Balen, Prof. Yeung, Prof. YawsonSP8 |  Evaluating digital diagnostic implementation through local health systems and service analysis PhD Student: Mamadu Baldeh, MRC Unit The Gambia (LSYTM) – Supervisors: Dr Balen, Prof de Witte, Prof YeungSP9 |  Co-design and development of user interfaces for digital diagnostics PhD Student: Angelina Ankah Amengu, University of Ghana – Supervisors: Dr Porat, Dr AbdulaiSP10 |  Integration and application of data from digital diagnostics for disease surveillance and control PhD Student: Francis Dzabeng, University of Ghana – Supervisors: Dr Abdulai, Mr Akogo, Dr Okell, Dr CostelloeThe involvement of community members, as potential end-users of the diagnostics, is central to the codesign process. Wider community engagement will be undertaken for the diagnostic accuracy studiesto ensure that the research is appropriate and approved by the local communities.</narrative>
  </description>
  <participating-org ref="GB-COH-04465125" type="80" role="4">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </participating-org>
  <participating-org ref="GB-CHC-1099776" type="21" role="4">
    <narrative xml:lang="en">Malaria Consortium</narrative>
  </participating-org>
  <participating-org type="90" role="1">
    <narrative xml:lang="en">National Institute of Health Research (NIHR)</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">MRC Unit The Gambia</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Masinde Muliro University of Technology and Sciences</narrative>
  </participating-org>
  <participating-org type="70" role="4">
    <narrative xml:lang="en">Mino Health AI</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Nairobi</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Institut de la Recherche en la Santé, Clinical Unit of Nanoro (IRSS-CRUN)</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">National Health Research and Training Institute (Zambia)</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">The Hague University of Applied Sciences</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Institute of Cancer Research</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Khartoum</narrative>
  </participating-org>
  <participating-org type="22" role="4">
    <narrative xml:lang="en">Patient Helping Fund Organization</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">Canterbury Christ Church University</narrative>
  </participating-org>
  <participating-org type="80" role="4">
    <narrative xml:lang="en">University of Ghana</narrative>
  </participating-org>
  <activity-status code="2"/>
  <activity-date type="1" iso-date="2022-08-01"/>
  <activity-date type="3" iso-date="2027-01-31"/>
  <recipient-country code="GM" percentage="10"/>
  <recipient-country code="GH" percentage="50"/>
  <recipient-country code="BF" percentage="10"/>
  <recipient-country code="KE" percentage="10"/>
  <recipient-country code="SD" percentage="10"/>
  <recipient-country code="ZM" percentage="10"/>
  <sector code="12110" percentage="20" vocabulary="1"/>
  <sector code="12250" percentage="20" vocabulary="1"/>
  <sector code="12262" percentage="40" vocabulary="1"/>
  <sector code="12196" percentage="20" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="1">
    <period-start iso-date="2024-08-01"/>
    <period-end iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">2153794</value>
  </budget>
  <transaction ref="Canterbury Christ Church University">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">115811</value>
  </transaction>
  <transaction ref="Institute of Cancer Research">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">19296</value>
  </transaction>
  <transaction ref="MinoHealth Ltd">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">85113</value>
  </transaction>
  <transaction ref="London School of Hygiene &amp; Tropical Medicine (LSHTM)">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">238217</value>
  </transaction>
  <transaction ref=" Imperial College London Income">
    <transaction-type code="1"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">2006806.1</value>
  </transaction>
  <transaction ref="Unité de Recherche Clinique de Nanoro">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">126294</value>
  </transaction>
  <transaction ref="Masinde Muliro University of Science and Technology (MMUST)">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">122101</value>
  </transaction>
  <transaction ref="Malaria Consortium">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">55775.32</value>
  </transaction>
  <transaction ref="University of Khartoum">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">110523</value>
  </transaction>
  <transaction ref="University of Ghana">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">403689</value>
  </transaction>
  <transaction ref="Tropical Diseases Research Centre (Zambia)">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">142871</value>
  </transaction>
  <transaction ref="University of Nairobi">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">53496.86</value>
  </transaction>
  <transaction ref=" Imperial College London Expenditure">
    <transaction-type code="4"/>
    <transaction-date iso-date="2025-07-31"/>
    <value currency="GBP" value-date="2025-07-31">1473187.18</value>
  </transaction>
</iati-activity><iati-activity last-updated-datetime="2026-10-08T12:37:26+00:00" xml:lang="en" default-currency="GBP" humanitarian="0" hierarchy="1">
  <iati-identifier>GB-COH-04465125-NIHRPA7196</iati-identifier>
  <reporting-org type="80" ref="GB-COH-04465125" secondary-reporter="0">
    <narrative xml:lang="en">Imperial College of Science, Technology and Medicine</narrative>
  </reporting-org>
  <title>
    <narrative xml:lang="en">Strengthening the Brazilian health system to better address racial/ethnic health inequities</narrative>
  </title>
  <description type="2">
    <narrative xml:lang="en">"Racial/ethnic health inequalities are large, unjust, preventable, and remediable. Health systems can exacerbate these inequalities by reflecting discrimination in wider society or by actively addressing these inequalities. Specific actions are needed to strengthen policies, financing, and clinical services to reduce racial health inequalities. &#13;
&#13;
This project will produce evidence on different health system factors and policies that exacerbate or reduce racial health inequalities in Brazil. It specifically aims to: 1) comprehensively measure racial health inequalities across Brazil, including changes over time and between geographical areas; 2) understand and quantify health system factors (e.g. policies, financing, health professionals, and discrimination) which drive these inequalities; 3) evaluate the impact of key national policies on racial health inequalities; 4) produce indicators for measuring racial health inequalities and a visual online dashboard; 5) involve and engage communities, politicians, civil society, and administrators in the research process; and 6) raise awareness and build capacity with online training courses, social media, and seminars.&#13;
&#13;
This work will be carried out in Brazil by the Institute of Health Policy Studies (IEPS) in Sao Paulo in collaboration with Imperial College London in the UK. Brazil is a key setting for this research as it has large health inequalities across racial groups and there are high-quality healthcare datasets. There are also important policies related to the health of the Black population that need evaluating, and there are effective civil society movements and engaged policymakers requesting evidence to inform their agendas. Policymakers and politicians, Black movement groups, and civil society informed this project and will join the research team to shape the research priorities, increase their knowledge of research, foster uptake of results, and inform new policies. Outputs include academic papers, technical and policy briefs, online data visualisations, newspaper articles, social media content, targeted discussions with policymakers, and workshops. This strategy aims to equip the Brazilian health system to better tackle racial health inequalities, build capacity of administrators, and empower communities to lead and campaign for change."</narrative>
  </description>
  <participating-org ref="GB-GOV-10" type="10" role="1">
    <narrative xml:lang="en">UK-Department of Health and Social Care</narrative>
  </participating-org>
  <participating-org ref="BR-CNPJ-32121994-0001-90" type="80" role="4">
    <narrative xml:lang="en">Instituto de Estudos Para políticas de Saúde</narrative>
  </participating-org>
  <participating-org ref="GB-COH-04465125" type="80" role="2">
    <narrative xml:lang="en">Imperial College London</narrative>
  </participating-org>
  <activity-status code="2"/>
  <activity-date type="2" iso-date="2025-05-01"/>
  <activity-date type="3" iso-date="2028-04-30"/>
  <contact-info type="1">
    <organisation>
      <narrative xml:lang="en">Imperial College London</narrative>
    </organisation>
    <person-name>
      <narrative xml:lang="en">Thomas Hone (PI)</narrative>
    </person-name>
    <email>t.hone@imperial.ac.uk</email>
  </contact-info>
  <contact-info type="1">
    <organisation>
      <narrative xml:lang="en">Instituto de Estudos para Políticas de Saúde (IEPS)</narrative>
    </organisation>
    <person-name>
      <narrative xml:lang="en">Bianca Reis</narrative>
    </person-name>
    <email>bianca.reis@ieps.org.br</email>
  </contact-info>
  <contact-info type="1">
    <organisation>
      <narrative xml:lang="en">Instituto de Estudos para Políticas de Saúde (IEPS)</narrative>
    </organisation>
    <person-name>
      <narrative xml:lang="en">Lucas Falcão</narrative>
    </person-name>
    <email>Lucas.falcao@ieps.org.br</email>
  </contact-info>
  <recipient-country code="BR" percentage="100"/>
  <sector code="12110" percentage="100" vocabulary="1"/>
  <default-flow-type code="10"/>
  <default-finance-type code="2"/>
  <default-aid-type code="A01" vocabulary="1"/>
  <default-tied-status code="4"/>
  <budget type="1" status="1">
    <period-start iso-date="2025-05-01"/>
    <period-end iso-date="2026-04-30"/>
    <value currency="GBP" value-date="2026-04-30">971456.62</value>
  </budget>
  <transaction>
    <transaction-type code="4"/>
    <transaction-date iso-date="2026-07-31"/>
    <value currency="GBP" value-date="2026-07-31">318329.00</value>
    <receiver-org ref="Instituto de Estudos para Políticas de Saúde (IEPS)" type="80"/>
  </transaction>
  <transaction ref="Imperial College London">
    <transaction-type code="4"/>
    <transaction-date iso-date="2026-07-31"/>
    <value currency="GBP" value-date="2026-07-31">412385.06</value>
    <receiver-org ref="Imperial College London" type="80"/>
  </transaction>
</iati-activity></iati-activities>
